Wellington Management Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$68.1M Sell
1,871,820
-577,678
-24% -$21M 0.01% 619
2025
Q1
$88.7M Sell
2,449,498
-8,045
-0.3% -$291K 0.02% 540
2024
Q4
$103M Sell
2,457,543
-1,707,881
-41% -$71.9M 0.02% 524
2024
Q3
$231M Sell
4,165,424
-390,743
-9% -$21.7M 0.04% 361
2024
Q2
$187M Buy
4,556,167
+458,192
+11% +$18.8M 0.03% 398
2024
Q1
$191M Sell
4,097,975
-317,054
-7% -$14.8M 0.03% 399
2023
Q4
$211M Sell
4,415,029
-780,851
-15% -$37.3M 0.04% 381
2023
Q3
$185M Buy
5,195,880
+18,359
+0.4% +$654K 0.04% 386
2023
Q2
$239M Buy
5,177,521
+76,374
+1% +$3.52M 0.05% 354
2023
Q1
$205M Sell
5,101,147
-101,537
-2% -$4.07M 0.04% 389
2022
Q4
$241M Sell
5,202,684
-843,354
-14% -$39.1M 0.05% 348
2022
Q3
$250M Buy
6,046,038
+1,631,598
+37% +$67.6M 0.05% 314
2022
Q2
$263M Buy
4,414,440
+1,044,195
+31% +$62.3M 0.05% 306
2022
Q1
$245M Buy
3,370,245
+492,842
+17% +$35.8M 0.04% 366
2021
Q4
$242M Buy
2,877,403
+369,128
+15% +$31M 0.04% 390
2021
Q3
$226M Buy
2,508,275
+2,108,704
+528% +$190M 0.04% 415
2021
Q2
$38.1M Sell
399,571
-239,691
-37% -$22.9M 0.01% 910
2021
Q1
$72.8M Sell
639,262
-27,925
-4% -$3.18M 0.01% 702
2020
Q4
$92.4M Sell
667,187
-86,437
-11% -$12M 0.02% 610
2020
Q3
$61.9M Buy
753,624
+140,038
+23% +$11.5M 0.01% 642
2020
Q2
$48M Sell
613,586
-222,971
-27% -$17.4M 0.01% 710
2020
Q1
$37.2M Sell
836,557
-447,553
-35% -$19.9M 0.01% 717
2019
Q4
$54.8M Sell
1,284,110
-1,975,852
-61% -$84.4M 0.01% 731
2019
Q3
$139M Sell
3,259,962
-3,220,277
-50% -$138M 0.03% 459
2019
Q2
$411M Buy
6,480,239
+98,369
+2% +$6.25M 0.09% 228
2019
Q1
$443M Buy
6,381,870
+385,788
+6% +$26.8M 0.1% 214
2018
Q4
$261M Buy
5,996,082
+721,174
+14% +$31.4M 0.07% 279
2018
Q3
$403M Sell
5,274,908
-815,235
-13% -$62.2M 0.08% 246
2018
Q2
$468M Sell
6,090,143
-171,063
-3% -$13.1M 0.1% 210
2018
Q1
$319M Buy
6,261,206
+402,086
+7% +$20.5M 0.07% 279
2017
Q4
$272M Buy
5,859,120
+871,955
+17% +$40.4M 0.06% 306
2017
Q3
$266M Sell
4,987,165
-259,976
-5% -$13.8M 0.06% 291
2017
Q2
$326M Buy
5,247,141
+666,197
+15% +$41.4M 0.08% 248
2017
Q1
$310M Sell
4,580,944
-674,247
-13% -$45.7M 0.07% 251
2016
Q4
$369M Buy
5,255,191
+1,122,268
+27% +$78.9M 0.09% 213
2016
Q3
$293M Sell
4,132,923
-55,261
-1% -$3.92M 0.07% 254
2016
Q2
$205M Buy
4,188,184
+55,754
+1% +$2.73M 0.05% 308
2016
Q1
$262M Buy
4,132,430
+1,835,196
+80% +$116M 0.07% 257
2015
Q4
$258M Buy
2,297,234
+420,588
+22% +$47.2M 0.07% 262
2015
Q3
$181M Buy
1,876,646
+203,866
+12% +$19.6M 0.05% 319
2015
Q2
$171M Buy
1,672,780
+97,936
+6% +$10M 0.04% 353
2015
Q1
$97.8M Buy
1,574,844
+207,458
+15% +$12.9M 0.03% 513
2014
Q4
$60M Buy
1,367,386
+291,658
+27% +$12.8M 0.02% 674
2014
Q3
$60.9M Buy
1,075,728
+451,149
+72% +$25.5M 0.02% 650
2014
Q2
$28M Sell
624,579
-7,840
-1% -$352K 0.01% 918
2014
Q1
$30.9M Buy
+632,419
New +$30.9M 0.01% 893